Innocan Pharma Corp. buy Bobysh
Start price
17.05.21
/
50%
€0.36
Target price
17.05.22
€0.80
Performance (%)
26.23%
End price
18.01.22
€0.45
Summary
This prediction ended on 18.01.22 with a price of €0.45. The prediction had a final performance of 26.23%. Bobysh has a follow-up prediction for Innocan Pharma Corp. where he still thinks Innocan Pharma Corp. is a Buy. Bobysh has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Innocan Pharma Corp. | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
According to Bobysh what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Bobysh for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy mit Kursziel 0,8
Current prediction by Bobysh for Innocan Pharma Corp.
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.20
24.03.24
24.03.24
€0.80
24.03.25
24.03.25
2.01%
15.05.24
15.05.24
Could be very worthwhile Investment >20% year
Stopped prediction by Bobysh for Innocan Pharma Corp.
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.20
13.12.22
13.12.22
€1.30
13.12.23
13.12.23
9.03%
14.12.23
14.12.23
Could be very worthwhile Investment >20% year
Innocan Pharma Corp.
Start price
Target price
Perf. (%)
€0.39
25.07.22
25.07.22
-
25.08.22
25.08.22
-2.21%
26.08.22
26.08.22
Could be very worthwhile Investment >20% year